News

Royalty Pharma missed analysts’ revenue expectations by 7% last quarter, reporting revenues of $564.7 million, up 5.3% year ...
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be reporting earnings tomorrow morning. Here’s what to look for. Royalty Pharma missed analysts’ revenue expectations by 7% last ...
Royalty Pharma missed analysts’ revenue expectations by 1.9% last quarter, reporting revenues of $594 million, flat year on year. ... Read our full analysis here, it’s free.